Importance of training for correct Turbuhaler use in preschool children

Acta Paediatrica, International Journal of Paediatrics

Volumn 87, Issue 8, 1998, Pages 842-847

  Agertoft, L ^a   Pedersen, S ^a  

^a KOLDING HOSPITAL   (Denmark)

Author keywords

Asthma; Dry powder inhaler; Inhalation therapy; Preschool; Training

Indexed keywords

BUDESONIDE; PLACEBO;

ARTICLE; ASTHMA; AUDIOVISUAL EQUIPMENT; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; FORCED EXPIRATORY VOLUME; HOME CARE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INSPIRATORY CAPACITY; MAJOR CLINICAL STUDY; NURSE; POWDER INHALER; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TRAINING;

ANALYSIS OF VARIANCE; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; NEBULIZERS AND VAPORIZERS; PATIENT EDUCATION; PEAK EXPIRATORY FLOW RATE; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 0031715490     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/080352598750013608     Document Type: Article

References (15)

1. Pedersen S, Hansen OR, Fuglsang G. Influence of inspiratory flow rate upon the effect of a Turbuhaler. Arch Dis Child 1990; 65: 308-10
2. Pedersen S. Inhaler use in children with asthma. Danish Med Bull 1987; 34: 234-49
3. Bisgaard H, Pedersen S, Nikander K. Use of budesonide Turbuhaler in young children suspected of asthma. Eur Respir J 1994; 7: 740-2
4. Bisgaard H. Aerosol treatment of young children. Eur Respir Rev 1994; 4: 17: 15-20
5. Newman SP, Moren F, Trofast E, Talaee N, Clarke SW. Terbutaline sulphate Turbuhaler: effect of inhaled flow rate on drug deposition and efficacy. Int J Pharm 1991; 74: 209-13
6. Borgström L. Deposition patterns with Turbuhaler. J Aerosol Med 1994; 7: S49-53
7. Newman SP, Morén F, Trofast E, Talaee N, Clarke SW. Terbutaline sulphate Turbuhaler: effect of inhaled flow rate on drug deposition and efficacy. Int J Pharmacol 1991; 74: 209-13
8. Olsson B. Aerosol particle generation from dry powder inhalers: can they equal pressurized metered dose inhalers? J Aerosol Med 1995; 8 Suppl 3: 13-9
9. Olsson B, Asking L. Critical aspects of the function of inspiratory flow driven inhalers. J Aerosol Med 1994; 7: S43-7
10. De Boer AH, Gjaltema D, Hagedoorn P. Inhalation characteristics and their effects on in-vitro drug delivery from dry powder inhalers. Part 2: effect of peak flow-rate (PIFR) and inspiration time on the in vitro drug release from three different types of commercial dry powder inhalers. Int J Pharmacol 1996; 138: 45-56
11. De Boer AH, Bolhuis GK, Gjaltema D, Hagedoorn P. Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers: Part 3: the effect of flow increase rate (FIR) on the in vitro drug release from the Pulmicort 200 Turbuhaler. Int J Pharmacol 1997; 153: 67-77: 67-77
12. Agertoft L, Nikander K, Pedersen S. Drug delivery to various age groups of children from two different inhalers. Am J Respir Crit Care Med 1997; 155: A972
13. Bisgaard H, Klug B, Burnell PK, Sumby BS. Use of inhalation profiles from paediatric asthmatics using the Diskus and Turbuhaler inhalers to evaluate product performance in-vitro. Am J Respir Crit Care Med 1996; 153: A75
14. Everard ML, Devadason SG, LeSouef PN. Early inspiratory flow determines the aerosol particle size distribution from a Turbuhaler. Eur Respir J 1996; 9: 204s
15. Szefler SJ, Kamada AK, Hughes D, Brenner AM, Gelfand EW. Alternative treatments for asthma: assessing the need. J Asthma 1992; 29: 91-7